Key Takeaways
- Micropep Technologies names Georg Goeres as Chief Executive Officer, effective July 1, 2025
- Goeres previously led Indigo Agriculture’s Biologicals Business Unit and brings 20+ years of international agriculture experience
- Founder and outgoing CEO Thomas Laurent transitions to strategic advisory role
- Under Laurent’s leadership, Micropep developed the Krisalix™ platform and raised over $60 million
- The leadership change comes as Micropep advances its first bio fungicide toward commercialization
Leadership Transition at Micropep Technologies
Micropep Technologies has announced the appointment of Georg Goeres as its new Chief Executive Officer, effective July 1, 2025. The company, which specializes in micropeptide-based solutions for sustainable crop protection, is transitioning leadership as it prepares for commercialization of its biological products.
Goeres brings more than two decades of global experience in the agriculture sector, having previously served as head of the Biologicals Business Unit at Indigo Agriculture. He has worked across multiple regions including Europe, Africa, Latin America, and the United States.
“I’m thrilled to take on the role as CEO of Micropep at this pivotal stage,” said Goeres. “The company’s peptide-based innovation engine is unlike anything else in the market. With our first bio fungicide advancing through regulatory processes and Krisalix™ poised to generate a suite of new biologicals, Micropep has the potential to fundamentally reshape the future of crop protection.”
Founder Thomas Laurent Steps Into Advisory Role
Micropep Technologies Marks Leadership Milestone
Goeres succeeds Thomas Laurent, who founded Micropep Technologies in 2016 and led its development from an academic project to an established deeptech platform operating across Europe and North America. During his tenure, the company built the Krisalix™ discovery platform, developed its first bio fungicide molecule, and secured over $60 million in funding.
“Micropep has reached an exciting inflection point,” said Kevin Smith, Chairman of the Board. “As we move toward commercialization, we are confident that Georg’s commercial expertise, deep sector knowledge, and leadership will guide Micropep through its next chapter of growth.”
Reflecting on the transition, Laurent stated: “From an academic collaboration to a global platform company, the journey has been extraordinary. Georg brings the right vision and skills to take Micropep into its next phase. After nine rewarding years, this is the right moment for me to step back and spend more time with my family. I remain deeply committed to Micropep’s long-term success.”
Micropep Technologies’ Strategic Outlook
Micropep Technologies has positioned itself as a developer of targeted crop protection solutions using proprietary micropeptides. The company’s Krisalix™ platform is designed to accelerate the discovery and development of new biological inputs. With its first bio fungicide moving through regulatory processes, the company aims to transition from R&D to commercial operations.
1 Comment